Seattle, WA – According to filings with the U.S. Securities and Exchange Commission, PharmID is raising $4,999,996.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Tim Gibbons played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About PharmID

PharmID was created to utilize MarqMetrix patented chemical verification technology to precisely and accurately identify chemical make-up of medications in the hospital and non-acute care marketplace. PharmID empowers the healthcare industry with the first true molecular verification of medication, through packaging, non-destructively, and within seconds. Pharmacists no longer have to rely on a fallible system or trust labels. PharmID gives them molecular proof. PharmID places the same advanced analytical technology used by pharmaceutical companies into the hands of healthcare professionals. PharmID solutions are compact and affordable for healthcare organizations of any size to use in everyday workflows.

To learn more about PharmID, visit http://pharmid.com/

Contact:
Tim Gibbons, Chief Executive Officer
206-992-3589
https://www.linkedin.com/in/tim-gibbons-4686722/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved